Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Neurotrack
Neurotrack

Neurotrack

Series A

US-based Neurotrack offers healthcare services, specializing in identifying and treating Alzheimer's disease.

HQ
Redwood City, CA, US
Founded
2012
Overview
Compare
Fundraising
Employees

Neurotrack specializes in digital cognitive assessments for early detection and management of Alzheimer's disease and other cognitive impairments. The company offers patient-administered tests that can be completed quickly, providing healthcare providers with efficient screening tools. Neurotrack's technology aims to distinguish cognitive impairment from normal aging, enabling timely interventions and improved patient outcomes.

The company's solutions cater to both healthcare providers and payers, focusing on early diagnosis and better population health management. Neurotrack's innovative approach to cognitive health assessment contributes to more effective treatment strategies and potentially improved quality of life for individuals at risk of or living with cognitive decline.

Neurotrack - Similar Companies

BrainCheck logo

BrainCheck

braincheck.com

CogniFit logo

CogniFit

cognifit.com

NeuroCog Trials logo

NeuroCog Trials

NeuroVision Imaging logo

NeuroVision Imaging

neurovision.com

Cognoa logo

Cognoa

cognoa.com

TNeuroPharma logo

TNeuroPharma

tneuropharma.com

Neuro42 logo

Neuro42

Cognision logo

Cognision

NeuroGeneces logo

NeuroGeneces

neurogeneces.com

NeuroFieldz logo

NeuroFieldz

neurofieldz.com

CognitiveCare logo

CognitiveCare

cognitivecare.com

GaitIQ logo

GaitIQ

gaitiq.com

Connected Mind logo

Connected Mind

NeuroForce1 logo

NeuroForce1

neuroforceone.com

BrainKey logo

BrainKey

brainkey.ai

Neurotrack - Quick Facts

Who are Neurotrack's competitors?

Companies similar to Neurotrack include BrainCheck, CogniFit, NeuroCog Trials and NeuroVision Imaging.

When was Neurotrack founded?

Neurotrack was founded in 2012.

Where is Neurotrack's headquarters located?

Neurotrack's headquarters is located in Redwood City, CA, US.

When was Neurotrack's last funding round?

Neurotrack's most recent funding round was for $10M (USD) in November 2022.

How much has Neurotrack raised to-date?

As of Nov 1, 2022, Neurotrack has raised a total of $60.4M (USD).

How many employees does Neurotrack have?

Neurotrack has 37 employees as of Feb 5, 2024.

Neurotrack - Classification

Ownership
  • Private
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Assessments
  • Healthcare
Tags
  • Healthtech
  • SaaS
NAICS
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 8 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research